This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bonfioli E, Berti L, Goss C, Muraro F, Burti L . BMC Psychiatry 2012; 12: 78.
Polymeropoulos MH, Licamele L, Volpi S, Mack K, Mitkus SN, Carstea ED et al Schizophr Res 2009; 108: 134–142.
Vik-Mo AO, Fernø J, Skrede S, Steen VM . BMC Pharmacol 2009; 9: 10–16.
Vik–Mo AO, Birkenaes AB, Fernø J, Jonsdottir H, Andreassen OA, Steen VM . Int J Neuropsychopharmacol 2008; 11: 679–684.
Zeng Y, Song JX, Shen XC . Phytother Res 2012; 26: 159–167.
Bei W-J, Guo J, Wu H-Y, Cao YJ . Evid Based Complement Altern Med 2012, Article number 970635: 1–10.
Altern Med Rev 2000; 5: 175–177.
Yin J, Xing H, Ye J . Metabolism 2008; 57: 712–717.
Curtis J, Newall H, Myles N, Shiers D, Samaras K . Acta Psychiatr Scand 2012; 126: 302–303.
Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H et al Eur J Endocrinol 2012; 166: 99–105.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foley, D. A hypothesized mechanism for the cardiovascular risk associated with antipsychotic drug exposure and a potential preventive treatment. Mol Psychiatry 19, 12–13 (2014). https://doi.org/10.1038/mp.2012.175
Published:
Issue date:
DOI: https://doi.org/10.1038/mp.2012.175